Cargando…

Chronic kidney disease and the global NCDs agenda

Detalles Bibliográficos
Autores principales:	Neuen, Brendon Lange, Chadban, Steven James, Demaio, Alessandro Rhyl, Johnson, David Wayne, Perkovic, Vlado
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717948/ https://www.ncbi.nlm.nih.gov/pubmed/29225940 http://dx.doi.org/10.1136/bmjgh-2017-000380

Ejemplares similares

Sodium-glucose cotransporter 2 inhibition: which patient with chronic kidney disease should be treated in the future?
por: Neuen, Brendon L, et al.
Publicado: (2020)

Decade of action on nutrition: our window to act on the double burden of malnutrition
por: Demaio, Alessandro Rhyl, et al.
Publicado: (2017)

Sexual reproductive health, NCDs and infectious diseases
por: Tumwine, James K
Publicado: (2022)

HIV and NCDs: inevitable interaction in resource limited settings
por: Tumwine, James K
Publicado: (2017)

A renewed call for transdisciplinary action on NCDs
por: Toebes, Brigit, et al.
Publicado: (2020)

Infections, NCDS, and the scourge of cyclones and Ebola in sub-Saharan Africa
por: Tumwine, James K
Publicado: (2019)

Editorial: Infectious diseases and NCDs persist despite concerted effort
por: Tumwine, James K
Publicado: (2021)

Health issues of concern to Africa and beyond: infections, NCDs and health systems inertia
por: Tumwine, James K
Publicado: (2018)

Editorial I: So, who wins? It is still: NCDs 3; Infections 2
por: Tumwine, James K
Publicado: (2022)

Addressing NCDs: Challenges From Industry Market Promotion and Interferences
por: Tangcharoensathien, Viroj, et al.
Publicado: (2019)

Burden of NCDs, Policies and Programme for Prevention and Control of NCDs in India
por: Srivastava, R K, et al.
Publicado: (2011)

Is Public Health System in LMICs Ready to Respond to the Ever Growing NCDs?
por: Haileamlak, Abraham
Publicado: (2015)

Are Countries Fulfilling the Promise They Made to Prevent Non-Communicable Diseases (NCDs)?
por: Haileamlak, Abraham
Publicado: (2017)

Time to clarify State obligations and accountability on NCDs with human rights instruments
por: Buse, Kent, et al.
Publicado: (2019)

Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS
por: Koshino, Akihiko, et al.
Publicado: (2022)

Towards a comprehensive global approach to prevention and control of NCDs
por: McKee, Martin, et al.
Publicado: (2014)

Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function: Data From the CANVAS Program
por: Neuen, Brendon L., et al.
Publicado: (2018)

Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis
por: Zhou, Zien, et al.
Publicado: (2021)

Association Between Circulating GDF‐15 and Cardio‐Renal Outcomes and Effect of Canagliflozin: Results From the CANVAS Trial
por: Sen, Taha, et al.
Publicado: (2021)

WHO Western Pacific Regional Action Plan for the Prevention and Control of NCDs (2014-2020)
por: Shin, Hai-Rim, et al.
Publicado: (2014)

New hypoglycemic agents and the kidney: what do the major trials tell us?
por: Smyth, Brendan, et al.
Publicado: (2018)

Sodium‐glucose co‐transporter‐2 inhibitors with and without metformin: A meta‐analysis of cardiovascular, kidney and mortality outcomes
por: Neuen, Brendon L., et al.
Publicado: (2020)

What drives political commitment for nutrition? A review and framework synthesis to inform the United Nations Decade of Action on Nutrition
por: Baker, Phillip, et al.
Publicado: (2018)

Women and NCDs: Overcoming the neglect
por: Bonita, Ruth, et al.
Publicado: (2014)

Towards a global agenda on ageing
por: Byass, Peter
Publicado: (2008)

Addressing the global health security agenda
por: The Lancet Infectious Diseases
Publicado: (2014)

Decolonizing global health: an agenda for research
por: Zakumumpa, Henry, et al.
Publicado: (2023)

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
por: Palmer, Suetonia C., et al.
Publicado: (2015)

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
por: Palmer, Suetonia C., et al.
Publicado: (2014)

The private sector, international development and NCDs
por: Hancock, Christine, et al.
Publicado: (2011)

Reframing NCDs? An analysis of current debates
por: Adjaye-Gbewonyo, Kafui, et al.
Publicado: (2019)

Ramadan Fasting and NCDs-Example of the Diabetes
por: Bencharif, Meriem, et al.
Publicado: (2022)

Addressing NCDs: Penetration of the Producers of Hazardous Products into Global Health Environment Requires a Strong Response: Comment on "Addressing NCDs: Challenges From Industry Market Promotion and Interferences"
por: Casswell, Sally
Publicado: (2019)

Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA(1c), disease duration and treatment intensity: results from the CANVAS Program
por: Young, Tamara K., et al.
Publicado: (2021)

Out of Africa, Into Global Health Security Agenda
por: Cho, Hae-Wol, et al.
Publicado: (2014)

Two Epidemics and Global Health Security Agenda
por: Cho, Hae-Wol, et al.
Publicado: (2015)

Putting Chagas disease on the global health agenda
Publicado: (2023)

National health policies and strategies for addressing chronic kidney disease: Data from the International Society of Nephrology Global Kidney Health Atlas
por: Neuen, Brendon L., et al.
Publicado: (2023)

Yoga for Control of Progression in the Early Stage of NCDs
por: Nadholta, Pooja, et al.
Publicado: (2023)

Sodium‐Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis
por: Arnott, Clare, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rubsjipl8sif7s6f1h1ed543af